LMR Partners »

Cytokinetics shares owned by LMR Partners

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by LMR Partners from 13F filings

Historical chart of LMR Partners investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by LMR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by LMR Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $34M 410k 83.49
2017-03-31 $158k 12k 13.03

More positions owned by LMR Partners

Ishares Tr Russell 2000 Etf Call Option (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Ishares Tr National Mun Etf Call Option (MUB)
Pdd Holdings Note10/0 (Principal)
On Semiconductor Corp Note5/0 (Principal)
Tripadvisor Put Option (TRIP)
Cytokinetics Note 4.000%11/1 (Principal)
Rivian Automotive Com Cl A Put Option (RIVN)
Advanced Micro Devices Call Option (AMD)
Dish Network Corporation Note 3.375% 8/1 (Principal)
BP Sponsored Adr (BP)
NVIDIA Corporation (NVDA)
United States Steel Corporation (X)
Carnival Corp Common Stock Put Option (CCL)

View all positions for LMR Partners

Top funds holding Cytokinetics

Vanguard Group
Wellington Management Company
Caption Management
T. Rowe Price Associates
Henderson Group
Boxer Capital
Citadel Advisors
Partner Fund Management
Logos Global Management
Lord, Abbett & Co
Millennium Management
Artal Group
Barclays
Gts Securities
Goldman Sachs Group

View all funds holding Cytokinetics